AI Advances Propel Ultrasound Imaging Market Through 2035
Global, Thursday, 22 May 2025.
By 2035, AI will significantly bolster ultrasound diagnostics, enhancing accuracy and patient outcomes with leading firms like GE and Samsung driving innovations in healthcare technology.
Market Growth and Technology Integration
The global AI in ultrasound imaging market, currently valued at $7.03 billion in 2025, is projected to reach $96.52 billion by 2032, representing a compound annual growth rate of 45.4% [1]. This dramatic expansion is being driven by increasing healthcare automation demands and significant technological advancements in diagnostic capabilities [2]. Leading companies including GE Healthcare, Siemens Healthineers, and Samsung are at the forefront of developing AI-powered solutions that enhance diagnostic accuracy and streamline clinical workflows [3].
Clinical Applications and Healthcare Impact
AI is transforming ultrasound imaging across multiple specialties, with particular emphasis on cardiology, obstetrics, orthopedics, and gastroenterology [2][3]. The technology is proving especially valuable in addressing critical healthcare workforce challenges, such as the significant radiologist shortage in the UK, where there is currently a 33% deficit in the workforce [1]. These AI-driven solutions are particularly crucial for early disease detection, showing remarkable capability in identifying fetal abnormalities, heart conditions, and tumors [2].
Innovation and Research Developments
Recent technological breakthroughs include the development of portable, AI-powered ultrasound devices by companies like Butterfly Network and Clarius, specifically designed for point-of-care applications [2]. Major healthcare initiatives are already showing promise, such as Google’s collaboration with Apollo Hospitals, which aims to provide 3 million free AI-powered screenings for various conditions including tuberculosis and breast cancer over the next decade [4]. These innovations are supported by comprehensive regulatory frameworks, including the National Artificial Intelligence Initiative Act, which continues to promote advanced AI research and applications in healthcare [2].
Global Market Expansion
While North America currently leads the market due to its robust healthcare infrastructure and substantial AI investments [2], emerging markets in Asia-Pacific, Latin America, and the Middle East are presenting significant growth opportunities [2][3]. The integration of cloud-based AI for remote diagnostics is particularly transformative, expanding access to advanced medical imaging in underserved and rural areas [2]. Healthcare organizations worldwide are actively investing in AI technologies, with the UK’s National Health Service allocating $26.8 million in June 2023 for AI imaging and decision-support tools [1].